Of the most downregulated pathways, patients with HER3 decrease show a negative enrichment in epithelial to mesenchymal transition, positive regulation of stem cell differentiation, possibly inferring cellular processes not involved in tumor progression. The gene discussed is ERBB3; the disease is neoplasm.